Skip to main content
Erschienen in: AIDS and Behavior 8/2023

22.01.2023 | Original Paper

Socio-ecological Barriers to Viral Suppression Among Transgender Women Living with HIV in San Francisco and Los Angeles, California

verfasst von: Jennifer P. Jain, Miranda Hill, Kristi E. Gamarel, Glenn-Milo Santos, Mallory O. Johnson, Torsten B. Neilands, Samantha E. Dilworth, Cathy J. Reback, Jae Sevelius

Erschienen in: AIDS and Behavior | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Troubling disparities in viral suppression persist among transgender (trans) women living with HIV in the US. We utilized baseline data from a randomized controlled trial of a behavioral intervention among trans women living with HIV in San Francisco and Los Angeles, to identify the socio-ecological correlates of biologically confirmed viral suppression (< 200 HIV-1 RNA copies/mL). Among 253 participants, the mean age was 43 (SD = 11), 46% identified as Black or African American and 35% were virally non-suppressed. In adjusted Poisson regression models, the following barriers to viral suppression were identified: injection drug use [adjusted risk ratio (aRR) 0.78, 95% CI 0.65–0.93, Z = − 2.64, p = 0.008], methamphetamine use (aRR 0.65, 95% CI 0.51–0.83, Z = − 3.45, p = 0.001), amphetamine use (aRR 0.62, 95% CI 0.44–0.87, Z = − 2.75, p = 0.006), homelessness (aRR 0.79, 95% CI 0.63–0.98, Z = − 2.06, p = 0.039), and sex work (aRR 0.60, 95% CI 0.41–0.86, Z = − 2.77, p = 0.009). These findings underscore the importance of interventions that address the socio-ecological barriers to viral suppression among trans women in urban settings.
Literatur
1.
Zurück zum Zitat Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.PubMedCrossRef Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.PubMedCrossRef
2.
Zurück zum Zitat Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109(1):e1–8.PubMedPubMedCentralCrossRef Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109(1):e1–8.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedPubMedCentralCrossRef Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451–2.PubMedCrossRef Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451–2.PubMedCrossRef
6.
Zurück zum Zitat Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Heal. 2015;2(3):228–34.CrossRef Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Heal. 2015;2(3):228–34.CrossRef
7.
Zurück zum Zitat Kalichman SC, Hernandez D, Finneran S, Price D, Driver R. Transgender women and HIV-related health disparities: falling off the HIV treatment cascade. Sex Health. 2017;14(5):469–76.PubMedCrossRef Kalichman SC, Hernandez D, Finneran S, Price D, Driver R. Transgender women and HIV-related health disparities: falling off the HIV treatment cascade. Sex Health. 2017;14(5):469–76.PubMedCrossRef
8.
Zurück zum Zitat Goldstein ZG. Overview of factors associated with HIV viral load suppression in transgender women. J Appl Lab Med. 2021;6(1):257–63.PubMedCrossRef Goldstein ZG. Overview of factors associated with HIV viral load suppression in transgender women. J Appl Lab Med. 2021;6(1):257–63.PubMedCrossRef
9.
Zurück zum Zitat Hughto JMW, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31.CrossRef Hughto JMW, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31.CrossRef
10.
Zurück zum Zitat Greenwood GL, Wilson A, Bansal GP, Barnhart C, Barr E, Berzon R, et al. HIV-related stigma research as a priority at the National Institutes of Health. AIDS Behav. 2022;26(1):5–26.PubMedCrossRef Greenwood GL, Wilson A, Bansal GP, Barnhart C, Barr E, Berzon R, et al. HIV-related stigma research as a priority at the National Institutes of Health. AIDS Behav. 2022;26(1):5–26.PubMedCrossRef
11.
Zurück zum Zitat Hirshfield S, Contreras J, Luebe RQ, Swartz JA, Scheinmann R, Reback CJ, et al. Engagement in HIV care among New York City transgender women of color: findings from the peer-led, TWEET intervention, a SPNS trans women of color initiative. AIDS Behav. 2021;25(1):20–30.PubMedPubMedCentralCrossRef Hirshfield S, Contreras J, Luebe RQ, Swartz JA, Scheinmann R, Reback CJ, et al. Engagement in HIV care among New York City transgender women of color: findings from the peer-led, TWEET intervention, a SPNS trans women of color initiative. AIDS Behav. 2021;25(1):20–30.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Eastwood EA, Nace AJ, Hirshfield S, Birnbaum JM. Young transgender women of color: homelessness, poverty, childhood sexual abuse and implications for HIV care. AIDS Behav. 2021;25(1):96–106.PubMedCrossRef Eastwood EA, Nace AJ, Hirshfield S, Birnbaum JM. Young transgender women of color: homelessness, poverty, childhood sexual abuse and implications for HIV care. AIDS Behav. 2021;25(1):96–106.PubMedCrossRef
13.
Zurück zum Zitat Lacombe-Duncan A, Bauer GR, Logie CH, Newman PA, Shokoohi M, Kay ES, et al. The HIV care cascade among transgender women with HIV in Canada: a mixed-methods study. AIDS Patient Care STDS. 2019;33(7):308–22.PubMedCrossRef Lacombe-Duncan A, Bauer GR, Logie CH, Newman PA, Shokoohi M, Kay ES, et al. The HIV care cascade among transgender women with HIV in Canada: a mixed-methods study. AIDS Patient Care STDS. 2019;33(7):308–22.PubMedCrossRef
14.
Zurück zum Zitat Maiorana A, Sevelius J, Keatley J, Rebchook G. “She is like a sister to me.” Gender-affirming services and relationships are key to the implementation of HIV care engagement interventions with transgender women of color. AIDS Behav. 2021;25(1):72–83.PubMedCrossRef Maiorana A, Sevelius J, Keatley J, Rebchook G. “She is like a sister to me.” Gender-affirming services and relationships are key to the implementation of HIV care engagement interventions with transgender women of color. AIDS Behav. 2021;25(1):72–83.PubMedCrossRef
16.
Zurück zum Zitat Melendez RM, Pinto R. ‘It’s really a hard life’: love, gender and HIV risk among male-to‐female transgender persons. Cult Health Sex. 2007;9(3):233–45.PubMedPubMedCentralCrossRef Melendez RM, Pinto R. ‘It’s really a hard life’: love, gender and HIV risk among male-to‐female transgender persons. Cult Health Sex. 2007;9(3):233–45.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Sevelius JM. Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color. Sex Roles. 2013;68(11):675–89.PubMedCrossRef Sevelius JM. Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color. Sex Roles. 2013;68(11):675–89.PubMedCrossRef
18.
Zurück zum Zitat Reback CJ, Rünger D, Fletcher JB. Physical and/or sexual abuse are associated with negative health outcomes among transgender women of color living with HIV. Violence Gend. 2017;4(4):130–6.CrossRef Reback CJ, Rünger D, Fletcher JB. Physical and/or sexual abuse are associated with negative health outcomes among transgender women of color living with HIV. Violence Gend. 2017;4(4):130–6.CrossRef
19.
Zurück zum Zitat Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, et al. Evidence for the model of gender affirmation: the role of gender affirmation and healthcare empowerment in viral suppression among transgender women of color living with HIV. AIDS Behav. 2019;25:64–71.CrossRef Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, et al. Evidence for the model of gender affirmation: the role of gender affirmation and healthcare empowerment in viral suppression among transgender women of color living with HIV. AIDS Behav. 2019;25:64–71.CrossRef
20.
Zurück zum Zitat Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.PubMedCrossRef Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.PubMedCrossRef
21.
Zurück zum Zitat Zuniga JA, Yoo-Jeong M, Dai T, Guo Y, Waldrop-Valverde D. The role of depression in retention in care for persons living with HIV. AIDS Patient Care STDS. 2016;30(1):34–8.PubMedPubMedCentralCrossRef Zuniga JA, Yoo-Jeong M, Dai T, Guo Y, Waldrop-Valverde D. The role of depression in retention in care for persons living with HIV. AIDS Patient Care STDS. 2016;30(1):34–8.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Carrico AW. Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV. Life Sci. 2011;88(21–22):940–7.PubMedCrossRef Carrico AW. Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV. Life Sci. 2011;88(21–22):940–7.PubMedCrossRef
23.
Zurück zum Zitat Reback CJ, Rünger D, Fletcher JB. Drug use is associated with delayed advancement along the HIV care continuum among transgender women of color. AIDS Behav. 2021;25(1):107–15.PubMedPubMedCentralCrossRef Reback CJ, Rünger D, Fletcher JB. Drug use is associated with delayed advancement along the HIV care continuum among transgender women of color. AIDS Behav. 2021;25(1):107–15.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Thomas JA, Irvine MK, Xia Q, Harriman GA. Service utilization and HIV outcomes among transgender women receiving Ryan White Part A services in New York City. PLoS ONE. 2021;16(7):e0253444.PubMedPubMedCentralCrossRef Thomas JA, Irvine MK, Xia Q, Harriman GA. Service utilization and HIV outcomes among transgender women receiving Ryan White Part A services in New York City. PLoS ONE. 2021;16(7):e0253444.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Klein PW, Psihopaidas D, Xavier J, Cohen SM. HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration’s Ryan White HIV/AIDS program: a retrospective study. PLoS Med. 2020;17(5):e1003125.PubMedPubMedCentralCrossRef Klein PW, Psihopaidas D, Xavier J, Cohen SM. HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration’s Ryan White HIV/AIDS program: a retrospective study. PLoS Med. 2020;17(5):e1003125.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Bukowski LA, Chandler CJ, Creasy SL, Matthews DD, Friedman MR, Stall RD. Characterizing the HIV care continuum and identifying barriers and facilitators to HIV diagnosis and viral suppression among black transgender women in the United States. J Acquir Immune Defic Syndr. 2018;79(4):413.PubMedPubMedCentralCrossRef Bukowski LA, Chandler CJ, Creasy SL, Matthews DD, Friedman MR, Stall RD. Characterizing the HIV care continuum and identifying barriers and facilitators to HIV diagnosis and viral suppression among black transgender women in the United States. J Acquir Immune Defic Syndr. 2018;79(4):413.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–3.PubMedCrossRef Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–3.PubMedCrossRef
28.
Zurück zum Zitat Riley ED, Vittinghoff E, Koss CA, Christopoulos KA, Clemenzi-Allen A, Dilworth SE, et al. Housing first: unsuppressed viral load among women living with HIV in San Francisco. AIDS Behav. 2019;23(9):2326–36.PubMedPubMedCentralCrossRef Riley ED, Vittinghoff E, Koss CA, Christopoulos KA, Clemenzi-Allen A, Dilworth SE, et al. Housing first: unsuppressed viral load among women living with HIV in San Francisco. AIDS Behav. 2019;23(9):2326–36.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Lipira L, Williams EC, Huh D, Kemp CG, Nevin PE, Greene P, et al. HIV-related stigma and viral suppression among African-American women: exploring the mediating roles of depression and ART nonadherence. AIDS Behav. 2019;23(8):2025–36.PubMedPubMedCentralCrossRef Lipira L, Williams EC, Huh D, Kemp CG, Nevin PE, Greene P, et al. HIV-related stigma and viral suppression among African-American women: exploring the mediating roles of depression and ART nonadherence. AIDS Behav. 2019;23(8):2025–36.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Hargreaves JR, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, Donnell D, et al. HIV stigma and viral suppression among people living with HIV in the context of universal test and treat: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa. J Acquir Immune Defic Syndr. 2020;85(5):561.PubMedPubMedCentralCrossRef Hargreaves JR, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, Donnell D, et al. HIV stigma and viral suppression among people living with HIV in the context of universal test and treat: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa. J Acquir Immune Defic Syndr. 2020;85(5):561.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Duff P, Goldenberg S, Deering K, Montaner J, Nguyen P, Dobrer S, et al. Barriers to viral suppression among female sex workers: role of structural and intimate partner dynamics. J Acquir Immune Defic Syndr. 2016;73(1):83.PubMedPubMedCentralCrossRef Duff P, Goldenberg S, Deering K, Montaner J, Nguyen P, Dobrer S, et al. Barriers to viral suppression among female sex workers: role of structural and intimate partner dynamics. J Acquir Immune Defic Syndr. 2016;73(1):83.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Fletcher JB, Kisler KA, Reback CJ. Housing status and HIV risk behaviors among transgender women in Los Angeles. Arch Sex Behav. 2014;43(8):1651–61.PubMedPubMedCentralCrossRef Fletcher JB, Kisler KA, Reback CJ. Housing status and HIV risk behaviors among transgender women in Los Angeles. Arch Sex Behav. 2014;43(8):1651–61.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13(1):482.PubMedPubMedCentralCrossRef Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13(1):482.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Greenwood G, Gaist P, Namkung A, Rausch D. Methodological and measurement advances in social determinants of HIV: view from NIH. AIDS Behav. 2021;25(2):127–32.PubMedPubMedCentralCrossRef Greenwood G, Gaist P, Namkung A, Rausch D. Methodological and measurement advances in social determinants of HIV: view from NIH. AIDS Behav. 2021;25(2):127–32.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010;55(0 2):132.CrossRef Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010;55(0 2):132.CrossRef
37.
Zurück zum Zitat Poteat T, Malik M, Scheim A, Elliott A. HIV prevention among transgender populations: knowledge gaps and evidence for action. Curr HIV/AIDS Rep. 2017;14(4):141–52.PubMedPubMedCentralCrossRef Poteat T, Malik M, Scheim A, Elliott A. HIV prevention among transgender populations: knowledge gaps and evidence for action. Curr HIV/AIDS Rep. 2017;14(4):141–52.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Sevelius JM, Neilands TB, Reback CJ, Castro D, Dilworth S, Kaplan RL et al. An intervention by and for transgender women living with HIV: Study protocol for a two-arm randomized controlled trial testing the efficacy of ‘Healthy Divas’ to improve HIV care outcomes. Front Reprod Health. 2021;27(3):665723. Sevelius JM, Neilands TB, Reback CJ, Castro D, Dilworth S, Kaplan RL et al. An intervention by and for transgender women living with HIV: Study protocol for a two-arm randomized controlled trial testing the efficacy of ‘Healthy Divas’ to improve HIV care outcomes. Front Reprod Health. 2021;27(3):665723.
39.
Zurück zum Zitat Gandhi RT, Tashima KT, Smeaton LM, Vu V, Ritz J, Andrade A, et al. Long-term outcomes in a large randomized trial of HIV-1 salvage therapy: 96-week results of AIDS Clinical Trials Group A5241 (OPTIONS). J Infect Dis. 2020;221(9):1407–15.PubMedCrossRef Gandhi RT, Tashima KT, Smeaton LM, Vu V, Ritz J, Andrade A, et al. Long-term outcomes in a large randomized trial of HIV-1 salvage therapy: 96-week results of AIDS Clinical Trials Group A5241 (OPTIONS). J Infect Dis. 2020;221(9):1407–15.PubMedCrossRef
40.
Zurück zum Zitat Finitsis DJ, Pellowski JA, Huedo-Medina TB, Fox MC, Kalichman SC. Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med. 2016;39(6):1043–55.PubMedCrossRef Finitsis DJ, Pellowski JA, Huedo-Medina TB, Fox MC, Kalichman SC. Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med. 2016;39(6):1043–55.PubMedCrossRef
41.
Zurück zum Zitat Melchior LA, Huba GJ, Brown VB, Reback CJ. A short depression index for women. Educ Psychol Meas. 1993;53(4):1117–25.CrossRef Melchior LA, Huba GJ, Brown VB, Reback CJ. A short depression index for women. Educ Psychol Meas. 1993;53(4):1117–25.CrossRef
42.
Zurück zum Zitat Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Measuring satisfaction and comfort with gender identity and gender expression among transgender women: development and validation of the psychological gender affirmation scale. Int J Environ Res Public Health. 2021;18(6):3298.PubMedPubMedCentralCrossRef Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Measuring satisfaction and comfort with gender identity and gender expression among transgender women: development and validation of the psychological gender affirmation scale. Int J Environ Res Public Health. 2021;18(6):3298.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Gender affirmation through correct pronoun usage: development and validation of the Transgender Women’s importance of Pronouns (TW-IP) Scale. Int J Environ Res Public Health. 2020;17(24):9525.PubMedPubMedCentralCrossRef Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Gender affirmation through correct pronoun usage: development and validation of the Transgender Women’s importance of Pronouns (TW-IP) Scale. Int J Environ Res Public Health. 2020;17(24):9525.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Landrine H, Klonoff EA, Corral I, Fernandez S, Roesch S. Conceptualizing and measuring ethnic discrimination in health research. J Behav Med. 2006;29(1):79–94.PubMedCrossRef Landrine H, Klonoff EA, Corral I, Fernandez S, Roesch S. Conceptualizing and measuring ethnic discrimination in health research. J Behav Med. 2006;29(1):79–94.PubMedCrossRef
45.
Zurück zum Zitat Comfort M, Reznick OG, Dilworth SE, Binson D, Darbes LA, Neilands TB. Sexual HIV risk among male parolees and their female partners: the relate project. J Health Dispar Res Pract. 2014;7(6):26.PubMedPubMedCentral Comfort M, Reznick OG, Dilworth SE, Binson D, Darbes LA, Neilands TB. Sexual HIV risk among male parolees and their female partners: the relate project. J Health Dispar Res Pract. 2014;7(6):26.PubMedPubMedCentral
46.
Zurück zum Zitat Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15(4):291–300.CrossRef Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15(4):291–300.CrossRef
47.
Zurück zum Zitat McNutt L-A, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–3.PubMedCrossRef McNutt L-A, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–3.PubMedCrossRef
48.
Zurück zum Zitat Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case–control studies. Am J Epidemiol. 2004;160(4):301–5.PubMedCrossRef Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case–control studies. Am J Epidemiol. 2004;160(4):301–5.PubMedCrossRef
49.
Zurück zum Zitat Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef
50.
Zurück zum Zitat Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292–8.PubMedPubMedCentralCrossRef Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292–8.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Bandoli G, Palmsten K, Chambers CD, Jelliffe-Pawlowski LL, Baer RJ, Thompson CA. Revisiting the table 2 fallacy: a motivating example examining preeclampsia and preterm birth. Paediatr Perinat Epidemiol. 2018;32(4):390–7.PubMedPubMedCentralCrossRef Bandoli G, Palmsten K, Chambers CD, Jelliffe-Pawlowski LL, Baer RJ, Thompson CA. Revisiting the table 2 fallacy: a motivating example examining preeclampsia and preterm birth. Paediatr Perinat Epidemiol. 2018;32(4):390–7.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, et al. Behavioral and health outcomes for HIV+ young transgender women linked to and engaged in medical care. LGBT Health. 2016;3(2):162–7.PubMedPubMedCentralCrossRef Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, et al. Behavioral and health outcomes for HIV+ young transgender women linked to and engaged in medical care. LGBT Health. 2016;3(2):162–7.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Rich KM, Wickersham JA, Valencia Huamaní J, Kiani SN, Cabello R, Elish P, et al. Factors associated with HIV viral suppression among transgender women in Lima, Peru. LGBT Health. 2018;5(8):477–83.PubMedPubMedCentralCrossRef Rich KM, Wickersham JA, Valencia Huamaní J, Kiani SN, Cabello R, Elish P, et al. Factors associated with HIV viral suppression among transgender women in Lima, Peru. LGBT Health. 2018;5(8):477–83.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Turner CM, Arayasirikul S, Wilson EC. Disparities in HIV-related risk and socio-economic outcomes among trans women in the sex trade and effects of a targeted, anti-sex-trafficking policy. Soc Sci Med. 2021;270:113664.PubMedCrossRef Turner CM, Arayasirikul S, Wilson EC. Disparities in HIV-related risk and socio-economic outcomes among trans women in the sex trade and effects of a targeted, anti-sex-trafficking policy. Soc Sci Med. 2021;270:113664.PubMedCrossRef
55.
Zurück zum Zitat Fitzgerald E, Patterson SE, Hickey D, Biko C, Tobin HJ. Meaningful work: transgender experiences in the sex trade. National Center for Transgender Equality; 2015. Fitzgerald E, Patterson SE, Hickey D, Biko C, Tobin HJ. Meaningful work: transgender experiences in the sex trade. National Center for Transgender Equality; 2015.
56.
Zurück zum Zitat Cowan FM, Davey CB, Fearon E, Mushati P, Dirawo J, Cambiano V, et al. The HIV care cascade among female sex workers in Zimbabwe: results of a population-based survey from the sisters antiretroviral therapy programme for prevention of HIV, an integrated response (SAPPH-IRe) trial. J Acquir Immune Defic Syndr. 2017;74(4):375–82.PubMedCrossRef Cowan FM, Davey CB, Fearon E, Mushati P, Dirawo J, Cambiano V, et al. The HIV care cascade among female sex workers in Zimbabwe: results of a population-based survey from the sisters antiretroviral therapy programme for prevention of HIV, an integrated response (SAPPH-IRe) trial. J Acquir Immune Defic Syndr. 2017;74(4):375–82.PubMedCrossRef
57.
Zurück zum Zitat Muth S, Len A, Evans JL, Phou M, Chhit S, Neak Y, et al. HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program. Addict Sci Clin Pract. 2017;12(1):1–10.CrossRef Muth S, Len A, Evans JL, Phou M, Chhit S, Neak Y, et al. HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program. Addict Sci Clin Pract. 2017;12(1):1–10.CrossRef
58.
Zurück zum Zitat Operario D, Soma T, Underhill K. Sex work and HIV status among transgender women: systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2008;48(1):97–103.PubMedCrossRef Operario D, Soma T, Underhill K. Sex work and HIV status among transgender women: systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2008;48(1):97–103.PubMedCrossRef
59.
Zurück zum Zitat Strathdee SA, West BS, Reed E, Moazen B, Moazan B, Azim T, et al. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr. 2015;69 Suppl 2(0 1):S110-7.PubMedCrossRef Strathdee SA, West BS, Reed E, Moazen B, Moazan B, Azim T, et al. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr. 2015;69 Suppl 2(0 1):S110-7.PubMedCrossRef
60.
Zurück zum Zitat Hoffman BR. The interaction of drug use, sex work, and HIV among transgender women. Subst Use Misuse. 2014;49(8):1049–53.PubMedCrossRef Hoffman BR. The interaction of drug use, sex work, and HIV among transgender women. Subst Use Misuse. 2014;49(8):1049–53.PubMedCrossRef
61.
Zurück zum Zitat Badgett MVL, Lau H, Sears B, Ho D. Bias in the workplace: consistent evidence of sexual orientation and gender identity discrimination. Los Angeles: The Williams Institute; 2007. Badgett MVL, Lau H, Sears B, Ho D. Bias in the workplace: consistent evidence of sexual orientation and gender identity discrimination. Los Angeles: The Williams Institute; 2007.
62.
Zurück zum Zitat Rhodes T, Platt L, Sarang A, Vlasov A, Mikhailova L, Monaghan G. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives. J Urban Health. 2006;83(5):911–25.PubMedPubMedCentralCrossRef Rhodes T, Platt L, Sarang A, Vlasov A, Mikhailova L, Monaghan G. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives. J Urban Health. 2006;83(5):911–25.PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Novak A. Toward a critical criminology of HIV criminalization. Crit Criminol. 2021;29(1):57–73.CrossRef Novak A. Toward a critical criminology of HIV criminalization. Crit Criminol. 2021;29(1):57–73.CrossRef
64.
Zurück zum Zitat Goldenberg SM, Deering K, Amram O, Guillemi S, Nguyen P, Montaner J, et al. Community mapping of sex work criminalization and violence: impacts on HIV treatment interruptions among marginalized women living with HIV in Vancouver, Canada. Int J STD AIDS. 2017;28(10):1001–9.PubMedPubMedCentralCrossRef Goldenberg SM, Deering K, Amram O, Guillemi S, Nguyen P, Montaner J, et al. Community mapping of sex work criminalization and violence: impacts on HIV treatment interruptions among marginalized women living with HIV in Vancouver, Canada. Int J STD AIDS. 2017;28(10):1001–9.PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Hasenbush A, Wilson B, Miyashita A, Sharp M. HIV criminalization and sex work in California. 2017. Hasenbush A, Wilson B, Miyashita A, Sharp M. HIV criminalization and sex work in California. 2017.
66.
Zurück zum Zitat Lama JR, Mayer KH, Perez-Brumer AG, Huerta L, Sanchez H, Clark JL, et al. Integration of gender-affirming primary care and peer navigation with hiv prevention and treatment services to improve the health of transgender women: protocol for a prospective longitudinal cohort study. JMIR Res Protoc. 2019;8(6):e14091.PubMedPubMedCentralCrossRef Lama JR, Mayer KH, Perez-Brumer AG, Huerta L, Sanchez H, Clark JL, et al. Integration of gender-affirming primary care and peer navigation with hiv prevention and treatment services to improve the health of transgender women: protocol for a prospective longitudinal cohort study. JMIR Res Protoc. 2019;8(6):e14091.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet. 2015;385(9962):55–71.PubMedCrossRef Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet. 2015;385(9962):55–71.PubMedCrossRef
68.
Zurück zum Zitat Shannon K, Crago AL, Baral SD, Bekker LG, Kerrigan D, Decker MR, et al. The global response and unmet actions for HIV and sex workers. The Lancet. 2018;392(10148):698–710.CrossRef Shannon K, Crago AL, Baral SD, Bekker LG, Kerrigan D, Decker MR, et al. The global response and unmet actions for HIV and sex workers. The Lancet. 2018;392(10148):698–710.CrossRef
Metadaten
Titel
Socio-ecological Barriers to Viral Suppression Among Transgender Women Living with HIV in San Francisco and Los Angeles, California
verfasst von
Jennifer P. Jain
Miranda Hill
Kristi E. Gamarel
Glenn-Milo Santos
Mallory O. Johnson
Torsten B. Neilands
Samantha E. Dilworth
Cathy J. Reback
Jae Sevelius
Publikationsdatum
22.01.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2023
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-03979-4

Weitere Artikel der Ausgabe 8/2023

AIDS and Behavior 8/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.